251 related articles for article (PubMed ID: 30132246)
1. Pien Tze Huang () Overcomes Doxorubicin Resistance and Inhibits Epithelial-Mesenchymal Transition in MCF-7/ADR Cells.
Chen X; Qi F; Shen AL; Chu JF; Sferra TJ; Chen YQ; Peng J
Chin J Integr Med; 2019 Aug; 25(8):598-603. PubMed ID: 30132246
[TBL] [Abstract][Full Text] [Related]
2. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
[TBL] [Abstract][Full Text] [Related]
3. Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network.
Shen A; Lin W; Chen Y; Liu L; Chen H; Zhuang Q; Lin J; Sferra TJ; Peng J
Int J Oncol; 2015 Feb; 46(2):685-90. PubMed ID: 25422078
[TBL] [Abstract][Full Text] [Related]
4. Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway.
Shen A; Chen H; Chen Y; Lin J; Lin W; Liu L; Sferra TJ; Peng J
Evid Based Complement Alternat Med; 2014; 2014():679436. PubMed ID: 25505925
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
[TBL] [Abstract][Full Text] [Related]
6. Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells.
Wei L; Chen P; Chen Y; Shen A; Chen H; Lin W; Hong Z; Sferra TJ; Peng J
Mol Med Rep; 2014 Jan; 9(1):261-6. PubMed ID: 24173665
[TBL] [Abstract][Full Text] [Related]
7. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway.
Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z
Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615
[No Abstract] [Full Text] [Related]
8. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
9. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
Tsou SH; Chen TM; Hsiao HT; Chen YH
PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
[TBL] [Abstract][Full Text] [Related]
10. Combination of 7-
Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
[TBL] [Abstract][Full Text] [Related]
11. Wulong Xiaozheng Wan medicated serum inhibits epithelial-mesenchymal transition in human gastric carcinoma cell line BGC823 by modulation of transforming growth factor-β1/Smad signaling.
Zhang Y; Wang B; Yang L; Li D; Yuan X; Guo X
J Tradit Chin Med; 2019 Jun; 39(3):380-392. PubMed ID: 32186010
[TBL] [Abstract][Full Text] [Related]
12. Pien Tze Huang Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Repressing PDGFRB/YAP/CCN2 Axis Activity.
Luo ZY; Tian Q; Cheng NM; Liu WH; Yang Y; Chen W; Zhang XZ; Zheng XY; Chen MS; Zhuang QY; Zhao BX; Liu CS; Liu XL; Li Q; Wang YC
Chin J Integr Med; 2024 Feb; 30(2):115-124. PubMed ID: 35947230
[TBL] [Abstract][Full Text] [Related]
13. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
14. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
Hu D; Li M; Su J; Miao K; Qiu X
Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
[TBL] [Abstract][Full Text] [Related]
15. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer.
Kim SJ; Seo I; Kim MH; Park JW; Kim S; Park WJ
Lipids Health Dis; 2023 Oct; 22(1):183. PubMed ID: 37885013
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
Chen J; Wang W; Wang H; Liu X; Guo X
Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
[TBL] [Abstract][Full Text] [Related]
18. Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway.
Cao LJ; Liu LY; Chen YQ; Han YY; Wei LH; Yao MY; Fang Y; Wu MZ; Cheng Y; Sferra TJ; Liu HX; Li L; Peng J; Shen AL
Chin J Integr Med; 2024 Jun; 30(6):515-524. PubMed ID: 38216838
[TBL] [Abstract][Full Text] [Related]
19. Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.
Chang X; Liu Z; Cao S; Bian J; Zheng D; Wang N; Guan Q; Wu Y; Zhang W; Li Z; Zuo D
Toxicol Appl Pharmacol; 2022 Feb; 436():115883. PubMed ID: 35031325
[TBL] [Abstract][Full Text] [Related]
20. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X
Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
